HGH Frag 176-191: Dosage, Benefits & Research Guide
What is HGH Frag 176-191?
HGH Fragment 176-191 corresponds to the final 16 amino acids of the human growth hormone molecule, a region associated with the hormone's fat-metabolizing activity. In preclinical research it has been investigated for its ability to stimulate lipolysis and inhibit lipogenesis in adipose tissue while showing little effect on IGF-1 levels, insulin sensitivity, or skeletal growth pathways. This selectivity has made it a subject of interest in metabolic and body-composition research models. Supplied as a lyophilized powder for in-vitro and laboratory research use only; not for human consumption.
HGH Frag 176-191 Research Applications
In published and preclinical research, HGH Frag 176-191 has been studied across the following areas:
- Lipolysis and fat metabolism research
- Body composition studies
- Growth hormone fragment signaling
- Metabolic research models
HGH Frag 176-191 in Research: Reconstitution & Study Concentrations
HGH Frag 176-191 is supplied as a lyophilized powder. For laboratory research it is reconstituted with bacteriostatic or sterile water; the solvent volume sets the working concentration. Published studies select concentrations specific to the assay or model system — there is no human dose, as HGH Frag 176-191 is not approved for human use. Researchers should reference the primary literature for the model in question and document the exact lot COA.
Worked example: a 5mg vial reconstituted with 2 mL of bacteriostatic water yields 2.50 mg/mL.
Open the reconstitution calculator